Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

NCT00118365 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

375

Enrollment

NIH

Sponsor class

Conditions

Precancerous Condition

Interventions

OTHER: placebo
DRUG: eflornithine
DRUG: sulindac
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)